Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration

Sara Nysom  Christiansen; Lykke Midtbøll Ørnbjerg; Simon Horskjær Rasmussen; AG Loft; Merete Lund Hetland; Mikkel Østergaard

Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration

Sara Nysom Christiansen, Lykke Midtbøll Ørnbjerg, Simon Horskjær Rasmussen, AG Loft, Merete Lund Hetland, Mikkel Østergaard

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme HOC

Originalsprog	Engelsk
Artikelnummer	PP20
Bogserie	Scandinavian Journal of Rheumatology, Supplement
Vol/bind	50
Udgave nummer	130
Sider (fra-til)	31-2
Antal sider	2
ISSN	0301-3847
Status	Udgivet - 2021

Citationsformater

Christiansen, S. N., Ørnbjerg, L. M., Rasmussen, S. H., Loft, AG., Hetland, M. L., & Østergaard, M. (2021). Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration. Scandinavian Journal of Rheumatology, Supplement, 50(130), 31-2. Artikel PP20.

Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration. / Christiansen, Sara Nysom ; Ørnbjerg, Lykke Midtbøll; Rasmussen, Simon Horskjær et al.
I: Scandinavian Journal of Rheumatology, Supplement, Bind 50, Nr. 130, PP20, 2021, s. 31-2.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Christiansen, SN , Ørnbjerg, LM, Rasmussen, SH, Loft, AG, Hetland, ML & Østergaard, M 2021, 'Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration', Scandinavian Journal of Rheumatology, Supplement, bind 50, nr. 130, PP20, s. 31-2.

Christiansen SN , Ørnbjerg LM, Rasmussen SH, Loft AG, Hetland ML , Østergaard M. Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration. Scandinavian Journal of Rheumatology, Supplement. 2021;50(130):31-2. PP20.

Christiansen, Sara Nysom ; Ørnbjerg, Lykke Midtbøll ; Rasmussen, Simon Horskjær et al. / Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration. I: Scandinavian Journal of Rheumatology, Supplement. 2021 ; Bind 50, Nr. 130. s. 31-2.

@article{49ff79683d874c65a52a1a7bb41e6628,

title = "Secular trends in baseline characteristics, treatment retention and response rates in 17 453 biona{\"i}ve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration",

author = "Christiansen, {Sara Nysom} and {\O}rnbjerg, {Lykke Midtb{\o}ll} and Rasmussen, {Simon Horskj{\ae}r} and AG Loft and Hetland, {Merete Lund} and Mikkel {\O}stergaard",

note = "COPECARE",

year = "2021",

language = "English",

volume = "50",

pages = "31--2",

journal = "Scandinavian Journal of Rheumatology, Supplement",

issn = "0301-3847",

publisher = "Taylor and Francis A.S.",

number = "130",

}

TY - ABST

T1 - Secular trends in baseline characteristics, treatment retention and response rates in 17 453 bionaïve psoriatic arthritis patients initiating tumour necrosis factor inhibitors: Results from the EuroSpA collaboration

AU - Christiansen, Sara Nysom

AU - Ørnbjerg, Lykke Midtbøll

AU - Rasmussen, Simon Horskjær

AU - Loft, AG

AU - Hetland, Merete Lund

AU - Østergaard, Mikkel

N1 - COPECARE

PY - 2021

Y1 - 2021

M3 - Conference abstract in journal

SN - 0301-3847

VL - 50

SP - 31

EP - 32

JO - Scandinavian Journal of Rheumatology, Supplement

JF - Scandinavian Journal of Rheumatology, Supplement

IS - 130

M1 - PP20

ER -